GLP-1 jabs such as Wegovy can trigger weight loss of up to 20%, but a BMJ study warns that users regain weight much faster after stopping treatment, about four times quicker, or 0.8 kg a month, than people who diet. Experts say appetite hormones rebound sharply, reinforcing the view that obesity is a chronic condition that may require long-term medication.